CRISPR/Cas9 Strategies for Disease Modeling and Drug Discovery | GenomeWeb
June 21, 2016
Sponsored by
The Jackson Lab

CRISPR/Cas9 Strategies for Disease Modeling and Drug Discovery


Research Fellow, UCSF Fellows Program, Clinical Fellow, Division of Infectious Diseases, UCSF Medical Practice 

Associate Director, Genetic Engineering Technologies, The Jackson Laboratory 

This online seminar outlined emerging applications for the CRISPR/Cas9 system in disease modeling and therapeutic discovery.

CRISPR/Cas9 is a revolutionary approach that enables rapid, economical model generation through precise genome editing. Every day, new studies continue to leverage the potential of CRISPR to generate novel strategies for modeling diseases and assessing therapeutic intervention.

During this webinar, our panelists discussed

  • Strategies for high-throughput generation of mouse models (KO/KI) using CRISPR/Cas9 
  • Special considerations for the use of the CRISPR/Cas9 system 
  • Genetic manipulation of primary human T cells using CRISPR/Cas9
Sponsored by

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.